Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
Intestinal Research · 30.04.2023 · 21 (2) · 226-234
DOI: 10.5217/ir.2022.00010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intestinal Research, erschienen am 30.04.2023. Verfasst von Karan Sachdeva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Indian Council of Medical Research, Center for Advanced Research in Intestinal Diseases.
Abstract (Originalsprache)
Background/Aims: Intestinal tuberculosis (ITB) and Crohn’s disease (CD) frequently present with a diagnostic dilemma because of similar presentation. Interferon-gamma release assay (IGRA) has been used in differentiating ITB from CD, but with sparse reports on its diagnostic accuracy in tuberculosis endemic regions and this study evaluated the same.
Methods
Patients with definitive diagnosis of ITB (n=59) or CD (n=49) who underwent IGRA testing (n=307) were retrospectively included at All India Institute of Medical Sciences, New Delhi (July 2014 to September 2021). CD or ITB was diagnosed as per standard criteria. IGRA was considered positive at >0.35 IU/mL.Relevant data was collected and IGRA results were compared between ITB and CD to determine its accuracy.
Results
Among 59 ITB patients (mean age, 32.6±13.1 years; median disease duration, 1 year; male, 59.3%), 24 were positive and 35 tested negative for IGRA. Among 49 CD patients (mean age, 37.8±14.0; median disease duration, 4 years; male, 61.2%), 12 were positive and 37 tested negative for IGRA. Hence, for diagnosing ITB, IGRA showed a sensitivity, specificity, positive and negative predictive values of 40.68%, 75.51%, 66.67%, and 51.39%, respectively. The area under the curve of IGRA for ITB diagnosis was 0.66 (95% confidence interval, 0.55–0.75). In a subset (n=64), tuberculin skin test (TST) showed sensitivity, specificity, positive and negative predictive values of 64.7%, 73.3%, 73.3%, and 64.71%, respectively. IGRA and TST were concordant in 38 (59.4%) patients with κ=0.17.
Conclusions
In a tuberculosis endemic region, IGRA had poor diagnostic accuracy for differentiating ITB from CD, suggesting a limited value of IGRA in this setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
Förderung
- Indian Council of Medical Research
- Center for Advanced Research in Intestinal Diseases
Zitieren
APA
Sachdeva, K., Kumar, P., Kante, B., Vuyyuru, S. K., Mohta, S., Ranjan, M. K., Singh, M. K., Verma, M., Makharia, G., Kedia, S., & Ahuja, V. (2023). Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas. Intestinal Research, 21(2), 226-234. https://doi.org/10.5217/ir.2022.00010
Vancouver
Sachdeva K, Kumar P, Kante B, Vuyyuru SK, Mohta S, Ranjan MK, et al. Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas. Intestinal Research. 2023;21(2):226-234. doi:10.5217/ir.2022.00010
BibTeX
@article{Sachdeva2023,
author = {Sachdeva, Karan and Kumar, Peeyush and Kante, Bhaskar and Vuyyuru, Sudheer K and Mohta, Srikant and Ranjan, Mukesh K and Singh, Mukesh K and Verma, Mahak and Makharia, Govind and Kedia, Saurabh and Ahuja, Vineet},
title = {Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas},
journal = {Intestinal Research},
year = {2023},
volume = {21},
number = {2},
pages = {226--234},
doi = {10.5217/ir.2022.00010}
}
EUVIMED